Interviews of leaders and innovators in pharmaceutical marketing.
Pharmaguy interviews Thibaud Guymard, Digital Marketing Manager at MSD France, who talks about Comuniti, a new online community that is part of MSD France's Univadis service exclusively for healthcare professionals.
Arnold Friede, Counsel to the law firm McDermott Will & Emery LLP, talks about organizing a collective response from representatives of the pharma industry to FDA's recent enforcement initiative on the use of sponsored links in search ads and more generally, on FDA's overall approach to regulating social media and the Internet.
Boost sales and develop direct relationships with consumers by imbuing Rx brands with human characteristics. Pharmaguy interviews Lea Katsanis, PhD, Marketing Professor at Concordia University's John Molson School of Business, about her research into Rx brand personalities as perceived by consumers and how pharmaceutical companies can boost sales and develop direct relationships with their consumers by imbuing their brands with human characteristics.
This podcast with Gideon Mantel, co-founder and CEO of Treato, discusses how a combination of deep healthcare domain expertise, advanced Natural Language Processing algorithms and
Guests Peter Shaw, MD, President and Jessica Labita, MBA, Vice President, Client Services, at MD Mindset, discuss the overall impact of sales professionals and teams use of the iPad in calls with healthcare providers as measured by MD Mindset's proprietary iSFE Tracker methodology.
Learn how you can decrease time to market and reduce costs to deploy strategic initiatives
A conversation with Ben Chodor, CEO of Happitique, about his company's standards that it will be using to certify medical, health, and fitness apps under Happtique's App Certification Program.
Pharmaguy interviews Preeti Pinto, former Executive Director & Head of Promotional Regulatory Affairs at AstraZeneca. We talk about the Advertising and Promotions Course that Preeti will teach at the Temple University School of Pharmacy this fall. Delve into the regulatory intricacies of Rx Drugs advertising!
Bremner will discuss the risks of some of the most commonly prescribed drugs and why he thinks the drug industry doesn't want consumers to know about them.